logo

Bellerophon Therapeutics Llc (BLPH)



Trade BLPH now with
  Date
  Headline
11/7/2017 8:38:55 AM Bellerophon Q3 Net Loss $7.6 Mln Or $0.22 Per Share
9/27/2017 8:30:42 AM Bellerophon Announces $23.4 Mln Private Placement
9/5/2017 8:34:58 AM Bellerophon Announces Positive Top Line Phase 2 Data Of INOpulse
8/7/2017 8:13:07 AM Bellerophon Therapeutics Q2 Net Loss Per Share $0.12 Vs Loss Of $0.39 Prior Year
8/3/2017 8:34:49 AM Bellerophon Announces FDA Agreement On Phase 2b Study Design For INOpulse In PH-ILD
5/15/2017 8:12:20 AM Bellerophon Therapeutics Q1 Loss/shr Widens To $0.60 From $0.54 Last Year
3/13/2017 7:49:09 AM Bellerophon Therapeutics Q4 Loss/shr $0.37 Vs. Loss/shr $0.83 Last Year
1/4/2017 8:16:08 AM Bellerophon Announces FDA Acceptance Of Modifications To INOpulse Pulmonary Arterial Hypertension Phase 3 Program
11/23/2016 6:30:51 AM Bellerophon Therapeutics Announces $12 Mln Public Offering; Expected To Close On Or About Nov. 29
11/8/2016 7:10:52 AM Bellerophon Q3 Net Loss $4.2 Mln Vs Loss $11.1 Mln Last Year